Medical Properties Trust (MPT)
Real Estate · Healthcare REIT · NYSE
A specialized REIT focused exclusively on the ownership and net-leasing of hospital infrastructure.
What Medical Properties Trust does
Medical Properties Trust is a real estate investment trust (REIT) focused on acquiring and developing net-leased hospital facilities. The company owns a portfolio of acute care hospitals, behavioral health facilities, and other medical real estate assets, leasing them to hospital operating companies.
Themes: healthcare real estate, hospital infrastructure, net lease investments
Fundamentals
- Price$2.74 as of 2026-10-20 close
- Market cap$1.6B as of 2026-08-10 (share count; price 2026-10-20)
- 1-year return-47.5% 2025-10-20 close $5.22 → 2026-10-20 close $2.74
- P/En/a negative earnings
- Net margin-28.5% FY2025, SEC XBRL
- ROE-6.0% FY2025, SEC XBRL
- ROICn/a No figure: its pre-tax income was zero or negative, so there is no tax rate to apply.
- Debt / equity2.13 borrowings, leases excluded / equity — 10-Q/10-K balance sheet 2026-03-31
- Revenue growth (YoY)-2.4% FY2025, SEC XBRL
- Revenue CAGR (3y)-14.3% SEC XBRL
- Beta0.68 as of 2026-09-03
- Last reported earnings2026-08-10 SEC EDGAR Form 8-K (Item 2.02)
Dividend: yield +10.6%; 1-year non-decreasing per-share dividend streak (SEC XBRL).
How MPT compares in its sector
- net profit marginbottom 10% 154 covered Real Estate peers, as of 2026-09-03
- return on equitybottom 25% 158 covered Real Estate peers, as of 2026-09-03
- 3-year revenue CAGRbottom 10% 155 covered Real Estate peers
- indicated dividend yieldtop 10% 132 covered Real Estate peers, as of 2026-09-03
Position among covered Real Estate companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
MPT is not currently in any published Top 10 list. Its scores are below.
Top 10 score
28.7 #1360 of 1,386 scored · #87 of 88 in Real Estate
Valuation 100th (price to book 0.4) and capital return 41st (net share count bought back over the year -0.1, consecutive years of dividend increases 1 year); weakest is trend (7th, trading below its 200-day average).
Scores as of 1 Oct 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 4. MPT was not in the scored universe at the latest run on 20 Oct 2026, so these scores are its last ones.
Dividend coverage (FY2025)
Covered by reported results. In FY2025, MPT's dividend was covered by reported results (operating-cash-flow payout 84%). This describes past coverage, not a forecast.
- Earnings payoutnot assessable earnings were not positive that year
- Operating-cash-flow payout84% dividends / operating cash flow — capital spending was not reported, so this does not subtract it
Coverage derived from reported SEC EDGAR XBRL figures for FY2025 (dividends paid vs. net income and free cash flow, same fiscal year). This describes PAST coverage for one fiscal year — it does not predict whether a dividend will be maintained, raised, or cut, and a one-year payout ratio can be distorted by non-recurring items. Informational only — not financial advice.
Quarterly results
| Quarter | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Q1 FY2026 2026-03-31 | $252M | $33M | $0.05 | -$14M |
| Q4 FY2025 2025-12-31 | $270M† | $17M† | $0.03† | $160M† |
| Q3 FY2025 2025-09-30 | $238M | -$78M | -$0.13 | $19M† |
| Q2 FY2025 2025-06-30 | $240M | -$98M | -$0.16 | $52M† |
| Q1 FY2025 2025-03-31 | $224M | -$118M | -$0.20 | $384000 |
| Q4 FY2024 2024-12-31 | $232M† | -$413M† | -$0.69† | $77M† |
| Q3 FY2024 2024-09-30 | $226M | -$801M | -$1.34 | $59M† |
| Q2 FY2024 2024-06-30 | $267M | -$321M | -$0.54 | $35M† |
† Not filed as a discrete quarter: derived from the company's own year-to-date figures (for example the fourth quarter as the fiscal year minus the first nine months). A derived per-share figure is approximate, because the share count moves within the year.
Balance sheet at 2026-03-31
- Cash and equivalents$425M
- Total debt$9.7B borrowings only; leases excluded
- Net debt$9.2B total debt − cash − short-term investments
From the company's own SEC 10-Q and 10-K filings (XBRL), re-read every week. Figures in US dollars as filed; informational only — not financial advice.
How Medical Properties Trust looks technically
Medical Properties Trust (MPT) is trading 41.3% below its 200-day average, the long-term trend line — a long-term downtrend. Its 50-day average crossed below its 200-day average about 113 trading days ago — a "death cross", a bearish long-term signal. A strong downtrend is in place — ADX, a 0–100 trend-strength gauge, is 59, with sellers in control. Momentum is beaten down — its 14-day RSI (a 0–100 momentum gauge) is 19, in oversold territory (below 30). It just made a new 20-day low, breaking below its recent trading range. It is 0.6% above its 52-week low (its lowest price of the past year).
Trend
8
| Distance from the 200-day | it is trading 41.3% below its 200-day average, the long-term trend line — a long-term downtrend | -41.3% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $3.65 | $3.65 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $4.67 | $4.67 |
| Swing structure | each recent peak has been lower than the one before it and each dip deeper — the pattern chart-watchers call a downtrend, which describes where price has already been and not where it goes next | lower highs and lower lows |
| Last swing turn | its last significant turn was a swing low 32 calendar days ago — the swings before that are what the structure reading is measured on | 32 sessions |
| Wave structure | its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in the fourth leg, a pullback against that downward direction; the labelling fails if price closes above 4.29. It is the only labelling that fits, and it describes the swings already printed, not what comes next. | possible downward five-wave sequence, in wave 4 |
| Since the 50/200 cross | its 50-day average crossed below its 200-day average about 113 trading days ago — a "death cross", a bearish long-term signal | 113 sessions |
| Trend strength (14-day ADX) | a strong downtrend is in place — ADX, a 0–100 trend-strength gauge, is 59, with sellers in control | 58.5 |
Momentum
3
| 14-day RSI | momentum is beaten down — its 14-day RSI (a 0–100 momentum gauge) is 19, in oversold territory (below 30) | 18.8 |
|---|---|---|
| Position in its 14-day range | it is trading right at the bottom of its 14-day range ($2.73 to $3.46) — its "stochastic" reading is 2 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been slipping within that range over the last few sessions. | 2.0 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, is in negative territory (momentum leaning bearish) | 13 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $6.47 | $6.47 |
|---|---|---|
| From the 52-week high | it is 57.7% below its 52-week high (its highest price of the past year) | -57.6% |
| Above the 52-week low | it is 0.6% above its 52-week low (its lowest price of the past year) | +0.6% |
| Below the 52-week high | it is 57.7% below its highest point of the past year | 57.6% |
| Since a 20-day breakout | it just made a new 20-day low, breaking below its recent trading range | 1 session |
| Since a 55-day breakout | it just made a new 55-day low, breaking below its recent trading range | 1 session |
| All-time high | its highest closing price on record is $24.29 (set on 2020-02-18) | $24.29 |
| Given back of the 52-week move | over the past year its closes ranged ($2.74 to $6.02), and it has recovered essentially none of its fall from last year’s high — 0% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $4.77 to $4.87. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 0.0% |
| From the all-time high | it is 88.7% below its all-time high | -88.7% |
| Nearest price level | it is trading 45.2% below a resistance level at $3.98 — a price it turned at four times since 2025-07-21, most recently on 2026-08-18. Since 2024-10-21 it has 0 such levels below the current price and 11 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | +45.2% |
| All-time low | its lowest closing price on record is $2.73 (set on 2026-10-20) | $2.73 |
| Above the all-time low | it is 0.6% above its all-time low | +0.6% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are unusually wide versus its own recent history (wider than about 99% of the past ~6 months) | 99th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $0.1414 between its high and its low — about 5.2% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $0.1414 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $2.78 and $3.73 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $2.78 – $3.25 – $3.73 |
| Typical daily range (% of price) | its price moves about 5.2% in a typical session — about typical for the companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 5.2% |
| Stretch from the 200-day average | it is trading 13.6 daily ranges below its 200-day average price (41.3% below it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 13.6 daily ranges below its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 1.17× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | not available for this company yet | n/a |
Candlestick patterns
2
| Since a doji | 6 sessions ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 6 sessions ago |
|---|---|---|
| Since a bearish engulfing | 2 sessions ago it opened above the previous session's close and finished below that session's open — a "bearish engulfing" pair, where one down day more than undid the up day before it | 2 sessions ago |
Price gaps
3
| Gap at the open | it opened on 2026-10-20 1.1% below the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | -1.1% |
|---|---|---|
| Open gap | it gapped 3.1% below the previous close 28 sessions ago and has not traded back through the level it left behind at 3.9 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | -3.1% |
| Gap filled | a 5.6% gap up opened on 2026-09-17 has been "filled" 22 sessions ago — price traded back through the level the gap left behind, and it took 1 session to close | 22 sessions ago |
Price streaks
1
| Closing streak | it has closed lower 3 sessions in a row, a -11.9% move over the run — an unbroken run of down days, which describes what has already happened and says nothing about the next session | 3 sessions down |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock lagged the market by 20.4 percentage points (the stock lost 19.4% while the market gained 1.0%) | -20.4% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 45.9 percentage points (the stock lost 42.3% while the market gained 3.6%) | -46.0% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 56.4 percentage points (the stock lost 47.9% while the market gained 8.5%) | -56.4% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 62.1 percentage points (the stock lost 47.5% while the market gained 14.6%) | -62.1% |
Signal agreement
2
| Bullish technical signals | 2 of the 9 technical signals we can compute for it are currently in a bullish state: its RSI momentum gauge is oversold (a beaten-down reading), near the bottom of its 14-day range (oversold) — these describe past price behaviour, not a forecast | 2 of 9 |
|---|---|---|
| Bearish technical signals | 7 of the 9 technical signals we can compute for it are currently in a bearish state: a "death cross" — its 50-day average is below its 200-day, trading below its 200-day average, a fresh 20-day low, MACD momentum is negative, a strong downtrend, with sellers in control, lagging the market over 6 months, trading below the Ichimoku cloud — these describe past price behaviour, not a forecast | 7 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 31% below the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-09-14 and projected forward over today's price, the side traders read as an established downtrend, with the band above acting as the level that would have to be cleared. The band itself is thick, spanning 9.1% of the share price, which is taken to mean a barrier that has held for a while and takes effort to cross. | -31.4% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 39% below the average price paid so far this year, so the typical buyer over that stretch is under water. That average is $4.46 — a volume-weighted average of daily closes over 201 sessions, not a true tick-by-tick VWAP. | -38.6% |
|---|---|---|
| Vs the average paid since it last reported | the price is 23% below the average price paid since it last reported on 2026-08-10 (its 10-Q), so the typical buyer over that stretch is under water. That average is $3.58 — a volume-weighted average of daily closes over 51 sessions, not a true tick-by-tick VWAP. | -23.5% |
Price levels it has turned at before
MPT last closed at $2.74 on 2026-10-20. Since 2024-10-21 it has turned at 0 prices below its last close and 11 above; the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $3.98 | Resistance | 45.2% above the last close | turned there four times · 2025-07-21 to 2026-08-18 |
| $4.14 | Resistance | 51.3% above the last close | turned there twice · 2024-11-07 to 2024-11-20 |
| $4.28 | Resistance | 56.2% above the last close | turned there twice · 2025-01-06 to 2026-06-26 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 4 of five, a pullback against that direction.
This labelling fails — stops being a possible reading at all — if it closes above $4.29.
It is the only labelling that fits these swings, though its proportions are not the textbook ones.
On past moves of this shape the leg has usually ended somewhere between $3.73 and $4.14 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
This reading has stood for 13 trading days, since 2026-10-02.
Read from daily closes as of 2026-10-20.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading below the 200-day moving average · Trading below the 50-day moving average · Oversold (14-day RSI below 30) · Near the 52-week low · Pulled back from the 12-month high · Broke down to a new 20-day low | Learn: moving average · golden cross · adx · rsi · breakout · fifty two week high low
Based on daily closing prices as of 2026-10-20. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Mean price target$5.13 range $4.25 – $7.00; median $5.00
Analyst estimates, as of 2026-10-17. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for MPT
- Consensus EPS estimate$0.00 next reporting period, as of 2026-10-17
- Estimate change, 30 days$0.00 from $0.00, on 2026-09-12, 35-day window
- Readings revised upward0% of 8 comparable readings
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["High levels of debt and interest expense burdening the balance sheet.","Significant exposure to tenant credit risks and operating performance.","Real estate impairment charges negatively impacting earnings."]
What changed in the latest 10-Q
AI-assisted comparison of MPT's 10-Q filed 2026-05-08 against the prior one filed 2025-11-07.
Management's Discussion & Analysis (MD&A)
- Added:
- Reference to '2025 Annual Report' (newer filing, filed 2026-05-08)
- Specification of geopolitical risks: 'such as ongoing armed conflicts in the Middle East and Ukraine' (newer filing)
- Reference to 'implementation of new and increased tariffs and other global trade disruptions' (newer filing)
- Phrase 'our financial condition and the financial condition of our tenants' (newer filing, expanded from older version)
- New bullet point on 'the risk that the timing, outcome, and terms of Prospect's causes of action, that is collateral for DIP and other fundings that remain outstanding, will not be consistent with those anticipated by the Company' (newer filing)
- Addition of 'our ability to effectuate the extension of the revolving portion of our credit facility (the "Credit Facility") to June 30, 2027' as separate risk factor (newer filing)
- Phrase 'rent ramp up provisions in the leases of former Steward and Prospect-operated facilities' (newer filing, expanded from older 'former Steward-operated facilities')
- Addition of 'tax audit results and' before 'changes in federal, state, or local tax laws' (newer filing)
- Removed:
- Reference to 'Annual Report on Form 10-K for the year ended December 31, 2024' (older filing, replaced with '2025 Annual Report')
- Reference to 'current reports on Form 8-K as we file them with the SEC under the Exchange Act' (older filing, simplified to 'on Form 8-K filed with the SEC')
- Phrase 'including the current U.S. government shutdown' from macroeconomic conditions bullet (older filing)
- Phrase 'rising inflation' (older filing, changed to 'persistent inflation' in newer)
- Phrase 'and may negatively impact the financial condition of our tenants' (older filing, expanded in newer)
- Longer Prospect-related risk: 'the risk that the outcome and terms of the bankruptcy restructurings of affiliates of Prospect will not be consistent with those we anticipate and the risk that we are unable to recover the value of our real estate and other investments in the Prospect portfolio as a result of the bankruptcy restructuring, within a reasonable timeframe or at all' (older filing, replaced with shorter version in newer)
- Phrase 'the risk that we are unable to successfully re-tenant or sell the remaining former Steward hospitals' (older filing, changed to 'any currently vacant properties' in newer)
- Phrase 'the risk that governments may exercise powers adverse' (older filing, changed to 'may take action adverse' in newer)
- Phrase 'our ability to remain in compliance with our financial covenants' (older filing, 'our' removed in newer)
- Phrase 'including debt in our joint venture arrangements' (older filing, removed from financing risk factor in newer)
- Phrase 'the potential impact from epidemics, pandemics' (older wording in older filing, changed to 'epidemics, pandemics or other public health crises' in newer)
- Phrase 'obtain or maintain equity or debt financing' (older filing, changed to 'obtain or maintain debt financing' in newer)
- Reworded:
- Changed 'and debt repayment transactions' to 'and other liquidity and debt repayment transactions' (newer filing)
- Changed 'persistent inflation' from 'rising inflation' (newer filing)
- Changed 'the risk that governments may exercise powers adverse to our ownership and other rights' to 'the risk that governments may take action adverse to our ownership and other rights' (newer filing)
- Changed 'remain in compliance with financial covenants' from 'remain in compliance with our financial covenants' (newer filing, possessive pronoun removed)
- Changed 'the economic, political and social impact of, and uncertainty relating to, the potential impact from epidemics, pandemics or other public health crises' to 'the economic, political, and social impact of, and uncertainty relating to, epidemics, pandemics or other public health crises' (newer filing, added comma after 'political' and removed 'the potential impact from')
- Changed 'changes in federal, state, or local tax laws' to 'tax audit results and changes in federal, state, or local tax laws' (newer filing, prepended new language)
- Notes:
- Both filings appear to be truncated at the end of the 'Key Factors that May Affect Our Operations' section, limiting full comparison of that section
- The older filing references December 31, 2024 fiscal year while the newer references 2025, consistent with the filing dates
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
1 open-market purchase and 0 open-market sales by insiders in the last 90 days, of which we have read Form 4 filings through 2026-10-16. The 5 days since 2026-10-16 have not been checked yet.
- Last 90 days · read to 2026-10-161 buy ($9545) · 0 sells — 1 buying insider
- Last 180 days · read to 2026-10-161 buy ($9545) · 0 sells — 1 buying insider
Activity heuristic: net buying (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-08-20. Based on Form 4 filings read through 2026-10-16; anything filed since is not yet included.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about MPT's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Short interest (FINRA)
MPT had 146,186,806 shares of reported short interest as of the 2026-09-30 FINRA settlement date (delayed, bi-monthly; not real-time).
MPT had 24.5% of its shares outstanding sold short as of the 2026-09-30 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 11.81 days to cover at the same settlement.
- Reported short interest (shares) 146,186,806
- Short interest (% of shares outstanding) 24.5%
- Prior settlement (shares) 145,296,024
- Reported change 0.61%
- Days to cover (reported) 11.81
Reported to FINRA as of the 2026-09-30 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Welltower (WELL)
- Ventas (VTR)
- Healthpeak Properties
- Physicians Realty Trust (DOC)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare MPT vs…
Medical Properties Trust is found in…
Frequently asked questions
What does Medical Properties Trust (MPT) do?
Medical Properties Trust is a real estate investment trust (REIT) focused on acquiring and developing net-leased hospital facilities. The company owns a portfolio of acute care hospitals, behavioral health facilities, and other medical real estate assets, leasing them to hospital operating companies.
What sector is Medical Properties Trust (MPT) in?
Medical Properties Trust (MPT) is classified in the Real Estate sector. Its industry is Healthcare REIT. It trades on NYSE.
Does MPT pay a dividend?
Yes — Medical Properties Trust (MPT) pays a dividend, with an indicated yield of about 10.59% and 1-year non-decreasing per-share dividend streak (SEC EDGAR XBRL) (market data, as of 2026-09-03). Informational only — not financial advice.
Who are Medical Properties Trust's (MPT) competitors?
Notable peers of Medical Properties Trust (MPT) include Welltower, Ventas, Healthpeak Properties and Physicians Realty Trust. This peer set is informational only — not financial advice.
Is Medical Properties Trust (MPT) overbought or oversold right now?
Medical Properties Trust (MPT) is currently in oversold territory (its 14-day RSI is 19, below 30) (as of 2026-10-20). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on MPT come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest; prices are market data, as of 2026-09-03; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-20.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.